Keywords
Transplanted tumor metastasis model
Spontaneous metastasis model
Experimental metastasis model
Submitted : 2024-10-23
Accepted : 2024-11-07
Published : 2024-11-22
Abstract
Breast cancer metastasis is a major cause of treatment failure and patient mortality. Mouse tumor models largely replicate the pathophysiological processes of human tumors. Establishing mouse models of breast cancer metastasis helps to elucidate metastatic mechanisms, and in vivo imaging techniques enable dynamic monitoring of tumor cell metastasis in animals. This paper summarizes the mechanisms of breast cancer metastasis, the development, and application of various mouse breast cancer distant metastasis models over the past decade, and evaluates the characteristics and efficacy of each model to provide references for future experimental studies.
References
Sung H, Ferlay J, Siegel RL, et al., 2021, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71(3): 209–249. https://doi.org/10.3322/caac.21660
Han B, Zheng R, Zeng H, et al., 2024, Cancer Incidence and Mortality in China, 2022. J Natl Cancer Cent, 4(1): 47–53. https://doi.org/10.1016/j.jncc.2024.01.006
Cancer Genome Atlas Network, 2012, Comprehensive Molecular Portraits of Human Breast Tumours. Nature, 490(7418): 61–70. https://doi.org/10.1038/nature11412
Allemani C, Matsuda T, Di Carlo V, et al., 2018, Global Surveillance of Trends in Cancer Survival 2000-14 (CONCORD-3): Analysis of Individual Records for 37 513 025 Patients Diagnosed with One of 18 Cancers from 322 Population-Based Registries in 71 Countries. Lancet, 391(10125): 1023–1075. https://doi.org/10.1016/S0140-6736(17)33326-3
Valastyan S, Weinberg RA, 2011, Tumor Metastasis: Molecular Insights and Evolving Paradigms. Cell, 147(2): 275–292. https://doi.org/10.1016/j.cell.2011.09.024
The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association, 2023, Guidelines for Breast Cancer Diagnosis and Treatment by China Anti-Cancer Association (2024 Edition). China Oncology, 33(12): 1092–1187.
Kennecke H, Yerushalmi R, Woods R, et al., 2010, Metastatic Behavior of Breast Cancer Subtypes. J Clin Oncol, 28(20): 3271–3277. https://doi.org/10.1200/JCO.2009.25.9820
Place AE, Jin Huh S, Polyak K, 2011, The Microenvironment in Breast Cancer Progression: Biology and Implications for Treatment. Breast Cancer Res, 13(6): 227. https://doi.org/10.1186/bcr2912
Dieu-Nosjean MC, Giraldo NA, Kaplon H, et al., 2016, Tertiary Lymphoid Structures, Drivers of the Anti-Tumor Responses in Human Cancers. Immunol Rev, 271(1): 260–275. https://doi.org/10.1111/imr.12405
Morvan MG, Lanier LL, 2016, NK Cells and Cancer: You Can Teach Innate Cells New Tricks. Nat Rev Cancer, 16(1): 7–19. https://doi.org/10.1038/nrc.2015.5
Qian BZ, Li J, Zhang H, et al., 2011, CCL2 Recruits Inflammatory Monocytes to Facilitate Breast-Tumour Metastasis. Nature, 475(7355): 222–225. https://doi.org/10.1038/nature10138
Murdoch C, Muthana M, Coffelt SB, et al., 2008, The Role of Myeloid Cells in the Promotion of Tumour Angiogenesis. Nat Rev Cancer, 8(8): 618–631. https://doi.org/10.1038/nrc2444
Foroni C, Broggini M, Generali D, et al., 2012, Epithelial-Mesenchymal Transition and Breast Cancer: Role, Molecular Mechanisms and Clinical Impact. Cancer Treat Rev, 38(6): 689–697. https://doi.org/10.1016/j.ctrv.2011.11.001
Heerboth S, Housman G, Leary M, et al., 2015, EMT and Tumor Metastasis. Clin Transl Med, 4: 6. https://doi.org/10.1186/s40169-015-0048-3
Aiello NM, Kang Y, 2019, Context-Dependent EMT Programs in Cancer Metastasis. J Exp Med, 216(5): 1016–1026. https://doi.org/10.1084/jem.20181827
Williams ED, Gao D, Redfern A, et al., 2019, Controversies Around Epithelial-Mesenchymal Plasticity in Cancer Metastasis. Nat Rev Cancer, 19(12): 716–732. https://doi.org/10.1038/s41568-019-0213-x
Brabletz T, Kalluri R, Nieto MA, et al., 2018, EMT in Cancer. Nat Rev Cancer, 18(2): 128–134. https://doi.org/10.1038/nrc.2017.118
Mendonsa AM, Na TY, Gumbiner BM, 2018, E-cadherin in Contact Inhibition and Cancer. Oncogene, 37(35): 4769–4780. https://doi.org/10.1038/s41388-018-0304-2
Imani S, Hosseinifard H, Cheng J, et al., 2016, Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Sci Rep, 6: 28587. https://doi.org/10.1038/srep28587
Nieto MA, Huang RY, Jackson RA, et al., 2016, EMT: 2016. Cell, 166(1): 21–45. https://doi.org/10.1016/j.cell.2016.06.028
Liu F, Gu LN, Shan BE, et al., 2016, Biomarkers for EMT and MET in Breast Cancer: An Update. Oncol Lett, 12(6): 4869–4876. https://doi.org/10.3892/ol.2016.5369
Su C, Zhang J, Yarden Y, et al., 2021, The Key Roles of Cancer Stem Cell-Derived Extracellular Vesicles. Signal Transduct Target Ther, 6(1): 109. https://doi.org/10.1038/s41392-021-00499-2
Song K, Farzaneh M, 2021, Signaling Pathways Governing Breast Cancer Stem Cells Behavior. Stem Cell Res Ther, 12(1): 245. https://doi.org/10.1186/s13287-021-02321-w
Dittmer J, 2018, Breast Cancer Stem Cells: Features, Key Drivers and Treatment Options. Semin Cancer Biol, 53: 59–74. https://doi.org/10.1016/j.semcancer.2018.07.007
Bai X, Ni J, Beretov J, et al., 2018, Cancer Stem Cell in Breast Cancer Therapeutic Resistance. Cancer Treat Rev, 69: 152–163. https://doi.org/10.1016/j.ctrv.2018.07.004
Wang S, Ma L, Wang Z, et al., 2021, Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression. Front Oncol, 11: 654452. https://doi.org/10.3389/fonc.2021.654452
Liu S, Cong Y, Wang D, et al., 2013, Breast Cancer Stem Cells Transition Between Epithelial and Mesenchymal States Reflective of Their Normal Counterparts. Stem Cell Reports, 2(1): 78–91. https://doi.org/10.1016/j.stemcr.2013.11.009
Ricardo S, Vieira AF, Gerhard R, et al., 2011, Breast Cancer Stem Cell Markers CD44, CD24 and ALDH1: Expression Distribution Within Intrinsic Molecular Subtype. J Clin Pathol, 64(11): 937–946. https://doi.org/10.1136/jcp.2011.090456
Tsukabe M, Shimazu K, Morimoto K, et al., 2013, Clinicopathological Analysis of Breast Ductal Carcinoma In Situ with ALDH1-Positive Cancer Stem Cells. Oncology, 85(4): 248–256. https://doi.org/10.1159/000355476
Baccelli I, Schneeweiss A, Riethdorf S, et al., 2013, Identification of A Population of Blood Circulating Tumor Cells from Breast Cancer Patients that Initiates Metastasis in A Xenograft Assay. Nat Biotechnol, 31(6): 539–544. https://doi.org/10.1038/nbt.2576
Goddard ET, Fischer J, Schedin P, 2016, A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer. J Vis Exp, 2016(118): 54903. https://doi.org/10.3791/54903
Yu C, Wang H, Muscarella A, et al., 2016, Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis. J Vis Exp, 2016(115): 53982. https://doi.org/10.3791/53982
Roarty K, Echeverria GV, 2021, Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis. Front Oncol, 11: 645698. https://doi.org/10.3389/fonc.2021.645698
Paschall AV, Liu K, 2016, An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis. J Vis Exp, 2016(114): 54040. https://doi.org/10.3791/54040
Peng ZH, Jogdeo CM, Li J, et al., 2022, Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model. Pharmaceutics, 14(8): 1725. https://doi.org/10.3390/pharmaceutics14081725
Liu Q, Li R, Lin J, 2022, No Difference Among Inhaled Anesthetics on the Growth and Metastasis of Murine 4T1 Breast Cancers in a Mouse Model of Spontaneous Metastasis. Front Pharmacol, 13: 794109. https://doi.org/10.3389/fphar.2022.794109
Du J, Li L, Ou Z, et al., 2012, FOXC1, A Target of Polycomb, Inhibits Metastasis of Breast Cancer Cells. Breast Cancer Res Treat, 131(1): 65–73. https://doi.org/10.1007/s10549-011-1396-3. Erratum in Breast Cancer Res Treat, 156(3): 609–610. https://doi.org/10.1007/s10549-016-3772-5
Ghajar CM, Peinado H, Mori H, et al., 2013, The Perivascular Niche Regulates Breast Tumour Dormancy. Nat Cell Biol, 15(7): 807–817. https://doi.org/10.1038/ncb2767
Wang Z, Duan Z, Luo Y, 2022, Establishment and Validation of Lung-Specific Metastatic Cell Subline of Mouse Breast Cancer. Basic and Clinical Medicine, 42(7): 1083–1091.
Liu Z, 2023, Development of Bionic Animal Model for Breast Cancer Brain Metastasis and Drug Treatment, dissertations, Jilin University.